Serum Hepatitis B Surface Antigen Levels Help Predict Disease Progression in Patients With Low Hepatitis B Virus Loads
Hepatology2012Vol. 57(2), pp. 441–450
Citations Over TimeTop 1% of 2012 papers
Tai‐Chung Tseng, Chun‐Jen Liu, Hung‐Chih Yang, Tung‐Hung Su, Chia‐Chi Wang, Chi‐Ling Chen, Cheng‐An Hsu, Stephanie Fang–Tzu Kuo, Chen‐Hua Liu, Pei‐Jer Chen, Ding‐Shinn Chen, Jia‐Horng Kao
Abstract
In HBeAg-negative patients with low viral loads and genotype B or C virus infection, a higher HBsAg level can predict disease progression. HBsAg <1,000 IU/mL in combination with low levels of HBV DNA and ALT help define minimal-risk HBV carriers.
Related Papers
- → Experimental study of the inhibitory effect of gantai capsule on HBsAg and HBeAg expression(2002)1 cited
- Inhibition of HBsAg and HBeAg Expression by ASODN of Various Regions of the HBV Genome(2005)
- Inhibitory effect of extracts of the core of lithion the expression of HBsAg and HBeAg in the HepG 2.2.15 cells(2004)
- Inhibitory effect of FFYC tablets(FFYC) on expression of HBsAg and HBeAg(2004)
- Experimental Study of the Inhibitory Effect of Gantai Capsule (肝泰胶囊) on HBsAg and HBeAg Expression(2002)